Appendix 7

AuthorKenneth Dorsney
Pages585-593
585
A–7
MOT IO N TO DI SM IS S PURSUANT TO FE D. R . CI V. P . 1 2( b )( 1) AND (6 )
IN THE UNITED STATES DISTRICT COURT
[Name of District]
[DISTRICT COURT CAPTION]
DEFENDANT’S OPENING BRIEF IN SUPPORT OF ITS MOTION TO DISMISS
FOR LACK OF SUBJECT MATTER JURISDICTION UNDER
FED. R. CIV. P. 12(b)(1) AND FOR FAILURE TO STATE A CLAIM
UNDER FED. R. CIV. P. 12(b)(6)
[Insert Table of Contents for Brief]
[Insert Table of Authorities for Brief]
)M -!230%!-$12!'%.&2(%/0.#%%$)-'1
Plaintiff [Name of Plaintiff] filed an Amended Complaint (“Complaint”) on
[Date], against [Name of Defendant] (“Defendant”), alleging, as the only cause of action,
patent infringement under 35 U.S.C. § 271(e)(2), i.e., the Hatch-Waxman Act. [Cite].1
Plaintiff’s theory for infringement is that Defendant’s filing of Abbreviated New Drug
Application (“ANDA”) No. 00-001, which seeks FDA approval to market generic
rosuvastatin tablets, infringes one or more claims of U.S. Patent Nos. 1 (“the ‘001
patent”) and 2 (“the ‘002 patent”) (collectively “the patents-in-suit”). [Cite].
Defendant’s answer or responsive pleading is due on [Date] [Cite], and in view of
the jurisdictional deficiencies in the Complaint, Defendant brings this instant Motion to
Dismiss for lack of subject matter jurisdiction under FED. R. CIV. P. 12(b)(1), and for
failure to state a claim upon which relief can be granted under FED. R. CIV. P. 12(b)(6)
(“Motion”).
))M 13,,!06.&!0'3,%-2
For at least the following three reasons, the Court should grant Defendant’s
Motion:
First, the Complaint fails to establish subject matter jurisdiction on its face, and
should, therefore, be dismissed pursuant to FED. R. CIV. P. 12(b)(1). Although the
Complaint suggests that subject matter jurisdiction is proper under 28 U.S.C. §§ 1331 and
1338(a), these statutes only indicate that district courts have original jurisdiction over
civil actions arising under federal laws, such as Title 35 of the Patent Act. The only Title
35 basis alleged for patent infringement here is under 35 U.S.C. § 271(e)(2). However,
because Defendant did not submit a paragraph IV certification as to the patents-in-suit
(i.e., explaining why the patents are not-infringed and/or invalid), legal precedence has
1 An earlier complaint was filed on [Date of Complaint] [Cite], but was superseded by
the [Date of Amended Complaint] Amended Complaint, because, inter alia, the initial
complaint did not include [Name], an assignee to one of the patents-in-suit.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT